Search Results 641-650 of 4607 for Diffuse
This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...
... Diffuse midline glioma, Oligodendroglioma, Diffuse glioma. Show more areas of focus for Terry C. Burns, M.D., Ph.D. Request an appointment · Conditions treated ...
Rochester, MN. Areas of focus: Brain tumor, Brain metastasis, Glioma, Oligodendroglioma, Diffuse glioma, Diffuse midline glioma. Ryan J ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of therapy ...
... Diffuse midline glioma, Oligodendroglioma, Diffuse glioma. Show more areas of focus for Terry C. Burns, M.D., Ph.D. Rich W. Byrne, M.D..
... Diffuse idiopathic skeletal hyperostosis, Tumors and masses, Spondylosis, Plexiform neurofibroma, Low back pain, Hemivertebra, Cervical radiculopathy ...
... diffuse large B-cell lymphoma that has returned after a period of improvement (relapsed) or does not respond to treatment (refractory). Before transplant ...
... Diffuse glioma. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Ann M. Murray, M.D.. Pediatrician; Pediatric Sleep Medicine ...
... Diffuse glioma. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Request an appointment · Conditions treatedSpecialty groups. Aug. 30, 2025. Share on ...
... Diffuse midline glioma, Tuberous sclerosis, Oligodendroglioma, Neurofibroma ... Diffuse glioma. Show more areas of focus for Wendy J. Sherman, M.D. ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.